172 related articles for article (PubMed ID: 10578313)
1. Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression.
Manu MA; Tanabe K; Ishikawa N; Tokumoto T; Oshima T; Shinmura H; Harano M; Otsubo S; Inui M; Kanematsu A; Fuchinoue S; Toma H
Transplant Proc; 1999 Nov; 31(7):2853-5. PubMed ID: 10578313
[No Abstract] [Full Text] [Related]
2. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H
Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
[No Abstract] [Full Text] [Related]
3. Tacrolimus therapy for ABO-incompatible kidney transplantation.
Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
[No Abstract] [Full Text] [Related]
4. Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression.
Washburn WK; Shaffer D; Simpson MA; Conway P; Madras PN; Monaco AP
Transplant Proc; 1996 Apr; 28(2):1015-6. PubMed ID: 8623214
[No Abstract] [Full Text] [Related]
5. Risk factors of acute tacrolimus nephrotoxicity in renal allografts.
Shimizu T; Tanabe K; Tokumoto T; Ishikawa N; Shimmura H; Oshima T; Toma H; Yamaguchi Y
Transplant Proc; 2000 Nov; 32(7):1914-6. PubMed ID: 11119998
[No Abstract] [Full Text] [Related]
6. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
7. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
8. Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
Suzuki K; Tanabe K; Tokumoto T; Shimizu T; Ishikawa N; Yagisawa T; Honda K; Nihei H; Toma H
Transplant Proc; 2000 Nov; 32(7):1730-2. PubMed ID: 11119910
[No Abstract] [Full Text] [Related]
9. Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression.
Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimaräes S
Transplant Proc; 2000 Dec; 32(8):2636-8. PubMed ID: 11134735
[No Abstract] [Full Text] [Related]
10. Tacrolimus for rescue of refractory renal allograft rejection.
Jordan ML; Naraghi R; Shapiro R; Smith D; Vivas CA; Scantlebury VP; Gritsch HA; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE
Transplant Proc; 1998 Jun; 30(4):1257-60. PubMed ID: 9636511
[No Abstract] [Full Text] [Related]
11. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
Yu L; Wang Y; Fu SJ; Cheng XJ
Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
[No Abstract] [Full Text] [Related]
12. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
13. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H
Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457
[No Abstract] [Full Text] [Related]
14. Five-year experience with tacrolimus rescue for renal allograft rejection.
Jordan ML; Naraghi RN; Shapiro R; Smith D; Vivas CA; Scantlebury VP; Gritsch HA; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE
Transplant Proc; 1997; 29(1-2):306. PubMed ID: 9123009
[No Abstract] [Full Text] [Related]
15. FK506 "rescue" therapy complicated by renal tubular acidosis in renal allograft recipients.
Goh BL; Tan SY
Transplant Proc; 1998 Nov; 30(7):3594-5. PubMed ID: 9838575
[No Abstract] [Full Text] [Related]
16. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
[No Abstract] [Full Text] [Related]
17. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
Dudley CR;
Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
[No Abstract] [Full Text] [Related]
18. Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months.
Budde K; Fritsche L; Smettan S; Schönberger B; Loening SA; Mai I; Bauer S; Waiser J; Neumayer HH
Transplant Proc; 1998 Jun; 30(4):1238-9. PubMed ID: 9636503
[No Abstract] [Full Text] [Related]
19. Improved outcome of minor-mismatched living renal allografts under tacrolimus immunosuppression.
Tanabe K; Ishida H; Tokumoto T; Shimmura H; Toda F; Omoto K; Makiyama K; Yagisawa T; Fuchinoue S; Teraoka S; Toma H
Transplant Proc; 2002 Aug; 34(5):1668-70. PubMed ID: 12176528
[No Abstract] [Full Text] [Related]
20. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
[Next] [New Search]